We are live on
!
Find out more
WCM
Weik Capital Management Portfolio holdings
AUM
$251M
1-Year Est. Return
12.95%
This Fund
S&P 500
This Quarter
Est. Return
+4.9%
1 Year Est. Return
+12.95%
3 Year Est. Return
+67.39%
5 Year Est. Return
+87.63%
10 Year Est. Return
+274.23%
AUM
$179M
AUM Growth
+$4.73M
(+2.7%)
Cap. Flow
-$2.63M
Cap. Flow
% of AUM
-1.47%
Top 10 Holdings %
Top 10 Hldgs %
37.47%
Holding
116
New
4
Increased
20
Reduced
57
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alerian MLP ETF
AMLP
|
+$581K |
| 2 |
Liberty Global Class C
LBTYK
|
+$249K |
| 3 |
PepsiCo
PEP
|
+$226K |
| 4 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$224K |
| 5 |
Schwab US Broad Market ETF
SCHB
|
+$215K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$760K |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$692K |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$529K |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$339K |
| 5 |
AGN
Allergan plc
AGN
|
+$271K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.02% |
| 2 | Consumer Discretionary | 16.14% |
| 3 | Consumer Staples | 15.09% |
| 4 | Communication Services | 11.29% |
| 5 | Healthcare | 7.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Sanofi
SNY
$103B
| $236K | 0.13% |
5,845
+350
| +6% | +$13.8K |
|
|
102
PepsiCo
PEP
$190B
| $225K | 0.13% |
+2,155
| New | +$226K |
|
103
Lindsay Corp
LNN
$1.13B
| $224K | 0.13% |
3,000
| – | – |
|
|
104
Schwab US Broad Market ETF
SCHB
$43.2B
| $221K | 0.12% |
+24,450
| New | +$215K |
|
|
105
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
| $220K | 0.12% |
+2,570
| New | +$224K |
|
|
ASNA
106
DELISTED
Ascena Retail Group, Inc.
ASNA
| $220K | 0.12% |
1,775
-25
| -1% | -$3.02K |
|
107
Vanguard Total Bond Market
BND
$157B
| $210K | 0.12% |
2,600
+150
| +6% | +$12.3K |
|
108
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
| $202K | 0.11% |
+1,750
| New | +$197K |
|
109
Donegal Group Class A
DGICA
$731M
| $175K | 0.1% |
10,000
| – | – |
|
|
110
Bausch Health
BHC
$2.58B
| – | – |
-30,955
| Closed | -$760K |
|
111
World Kinect Corp
WKC
$2.04B
| – | – |
-5,750
| Closed | -$266K |
|
|
HRC
112
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| – | – |
-3,500
| Closed | -$217K |
|
|
AGN
113
DELISTED
Allergan plc
AGN
| – | – |
-1,175
| Closed | -$271K |
|
Similar funds
WSIB
TODC
MM
TFP
BWA
EWM
CWM
PF
Weik Capital Management's Q4 2016 Portfolio in Review
As of Q4 2016, Weik Capital Management held 116 positions worth $179M, up 2.7% from $174M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Weik Capital Management's Q4 2016 filing shows 4 new, 20 increased, 57 reduced and 4 closed positions. Its largest new stake was PepsiCo: 2,155 shares worth $225K. The largest sale was Bausch Health, an estimated $760K.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
- Weik Capital Management's largest Q4 2016 buy was PepsiCo: 2,155 shares worth $225K.
- Weik Capital Management added most to Alerian MLP ETF in Q4 2016, an estimated $581K increase.
- Weik Capital Management's biggest Q4 2016 reduction was Berkshire Hathaway Class A, cutting an estimated $692K.
- Weik Capital Management fully exited Bausch Health in Q4 2016, selling an estimated $760K.
- Weik Capital Management's ten largest holdings make up 37% of its $179M portfolio in Q4 2016.
- Weik Capital Management opened 4 new positions and closed 4 in Q4 2016.
- Weik Capital Management's portfolio value rose 2.7% quarter-over-quarter to $179M.
Based on Weik Capital Management's 13F filing for Q4 2016, filed 9 Feb 2017.